Oligomycin
WikiDoc Resources for Oligomycin |
Articles |
---|
Most recent articles on Oligomycin |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Oligomycin at Clinical Trials.gov Clinical Trials on Oligomycin at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Oligomycin
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Oligomycin Discussion groups on Oligomycin Patient Handouts on Oligomycin Directions to Hospitals Treating Oligomycin Risk calculators and risk factors for Oligomycin
|
Healthcare Provider Resources |
Causes & Risk Factors for Oligomycin |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Oligomycins are macrolides created by Streptomyces that can be poisonous to other organisms.
Function
They have use as antibiotics.
In addition, oligimycin inhibits ATP synthase by blocking its proton channel, which is necessary for oxidative phosphorylation of ADP to ATP (energy production).
Administering oligomycin to an individual can result in very high levels of lactate accumulating in the blood and urine.[citation needed]